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. ·······i ········:·······t········!..······!··. .·. .·!· · ..·· j ! ( . ....., .... I' ..... ········;. .. .·..· :. .·..···]' ··· T··..········.. ': , ··· ····t·······I········ i········I········:········j ·· i········:,·······i········ . .37. ; · · · · · t ·· · · · · · ·~· ·· · · · · · · ·· · · · · · · · 1· · · · · ..of· · · · · · · · f · · · · · · · ·~· ·· · ·· · · For man y years, I have been interested in th e headaches th at my vestibular patien ts have experienced. According to the customary understanding of migraine headache, dizziness is part of m igraine.!" However, based on my 40 years of person al observations, I hold a contrarian view of this headache's etiology. I believe that th e migr aines in my vestibular patients are otologic in origin. In this article I will explain why, illustr atin g my point with a case report.
A common anatomic basis for th e understanding of headac he is the vestibulospin al (colic) reflex that is Fro m Neurotologic Assoc iates, PC, New York City.
258· www.entjournal.com tr iggered from the inner ears. Th is reflex is currently receiving much attention as th e basis for measuring vestibular-evoked myogenic potentials.' When I have successfully tr eated recent-onset dizziness medic ally rath er th an surgically, I have seen chronic migraines disapp ear or significantl y abate in many cases.
I have also seen migraine resolve in a patient with hearing loss and no history of dizziness. The patient was a 59-year-o ld m an-a childhood friend of mine in Canada. In December 1989, he called me to say that he had earlier exper ienced a sudde n hearing loss in his Circle 114 on Reader Service Card AUDITORY AND VESTIBULAR M EDICINE CLINIC right ear, for which he underwent treatment with a course of corticosteroids. He also had noted considerable associated tinnitus, but no dizziness or aura l fullness. His hearing returne d within 1 month of th erapy, and the tinnitus resolved for th e most part some time later.
I suggested to my friend th at if his travels ever brought him to New York City, I would like to examine him. I eventually did examine him 8 months after the onset of his hearing loss. He explained that his right ear was hypersensitive to some sounds but th at his overall hearing in th at ear was not as good as the hearin g in his left ear. He was also exper iencing some periodic tinnitus in th e right ear, but again no dizziness or aura l fullness.
My friend also related a history of migraines that extended back to when he was a teenager. (His father also had a history of headaches, which he eventually "outgrew.") My friend 's headaches were hemicranial (mostly on the right) and extended to the back of the eye on the affected side. At the time of his visit, he was taking 12 to 14 doses of a triptan drug (sum atr iptan) each month. He took th e sumat riptan only for headaches th at he described as "wall bangers."When a headache was not severe eno ugh to require a triptan, he would take a com bination of aspirin, phenaceti n, caffeine, and codeine that is marketed in Canada; he was taking 4 or 5 doses per week of this preparation.
The results of my examinations were not extraordinary with the exception of a few soft findings. There was some possible hyperacusis to the 2,048-Hz tuning fork in the right ear. My patient also had difficulty performing th e shar pene d tandem Romb erg test with either foot forwar d, more so with the right foot forwar d. He had no nuchal or occipital tenderness. In the right ear, audiometry identified a mild mixed hear ing loss at 250 and 500 Hz and a mild sensorineural hearing loss at 6 and 8 kHz ; the speech reception threshold was 20 dB and the speech discrimination score was 92% at 55 dB. Findings on tympanometry and acous tic stapedial reflex testing were norm al.
Based on my exper ience with headache in dizzy patients, I suggested to my friend th at his m igraine m ight have a vestibular component, even though he had not experienced any dizziness. He expressed interes t in exploring this possibility. My first step was to look for objective evidence of a vestibular disorder with electronystagmography (ENG) (figures) . No spo ntaneo us, positional, or neck tors ion nystagm us was elicited, and the results of th e alternate binaur al caloric test were normal. However, findings on the simultaneous bin-260 · www.entjournal.com aural bithermal test were abnormal, showing a definite left-beating nystagmus with the simultaneous cool stimul us. The sim ultaneous warm stimulus did not main tain a baseline on th e recording bu t suggested a right-beating nystagmu s. In either instance, a type 2 reduced vestibular response left or a type 4 left-beat ing nystagmus with th e simultaneous cool stim ulus demonstrated a sensory mismatch efferent to the vestibular nuclei .
The next step was to search for the cause of the abnormal ENG results. Ultrathin-section com puted tomography of the tem poral bones detecte d evidence of bilateral capsular otosclerosis, more prominent in th e left ear. Findings on labor ato ry evaluatio ns were normal except for th e results of the glucose tolerance test, which showed a fluctua ting blood sugar level with an exaggerated drop at the th ird hour and evidence of hyperinsulinemia, according to the criteria developed by Kraft." I prescribed my then-current medical treatment for both the otosclerosis and the metabolic disor ders. To address the otosclerosis, I chose etidro nate, calcium carb on ate, and vitam in D; the etidro nate was to be taken daily for 2 weeks at a tim e between 4-week rest periods, and th e calcium carbonate and vitamin D were to be taken daily. I trea ted the metabolic factors with a modified hypog lycemic diet that was low in fat; the regimen involved three meals and three interval snacks per day.
Within 3 months of medica l treatment, my friend reported that his migraines had becom e less frequent. At 6 months, he was requiring only 4 to 6 doses of a trip tan per month. At that point, I switched him from etidronate to alendronate and switched him to sodium monofluorophosphate and calcium carbonate in a fixed preparation. After 3 years on th is regimen, he was taking 3 to 5 doses of a tr iptan per month. He said that his headaches were less severe, and he volunteered that he felt less morning grogginess. The duration of his headaches rema ined the same. I switched him from alendro nate to risedronate 30 mg twice weekly. After he appeared to reach a plateau , I redu ced th e risedronate dosage to once a week.
Six months later, my patient reported that he had been able to go a coup le of months without needing a triptan, but on average he had been taking it twice a month. He was not taking any other analgesics. He said he rarely woke up with a groggy feeling anymore. I changed his risedronate dosage back to 30 mg twice weekly in response to a decline in hearing at th e very high frequ encies. One year later, I reduced the risedronate dosage back to 30 mg once weekly. Byyear 5 of therapy, my friend's triptan requirement was down to 1 per month. I tapered the risedronate regimen to 1 dose every 2 weeks for 3 months, then 1 dose every 3 weeks for 3 months, then 1 dose once a month for 3 months. As this taper proceeded, his headaches would occur on ly when he had a head cold.
At 7 years and 6 months of therapy, my friend had not experienced a headache in 16 months. By that time, he was taking 1 dose of risedronate every other month; 6 months later, I discontinued the risedronate altogether.
In this patien t, a treatment directed at a vestibu lar etiology-one that was similar to treatments directed at solely otologic disorders-seems to have reversed nearly a lifetime of migraine. Current concep ts in our understanding of migraine are based on a vulnerability threshold, a neurovascular component, and spreading cortical depressio n." It seems reasonable that a mismatched sensory-efferent input from the labyrinths could provide a component of the vulne rability threshold and act as a trigger for a subsequent neurovascular component and spreading cortic al depression.P'" It is not clear whether the underlying vestibular component is the on ly explanation or if other underlying sensory mismatches may act as similar triggers .
